The lag between effectiveness and cost-effectiveness evidence of new drugs: Implications for decision-making in health care

European Journal of Health Economics

Volumn 4, Issue 4, 2003, Pages 313-318

  Stoykova, Boyka ^a   Drummond, Michael ^b   Barbieri, Marco ^b   Kleijnen, Jos ^b  

^a BRUNEL UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Cost effectiveness; Decision making; Evidence; Guidance; Lag

Indexed keywords

ALPHA INTERFERON; CELECOXIB; DOCETAXEL; DONEPEZIL; EPTIFIBATIDE; ETODOLAC; FLUDARABINE; GALANTAMINE; GEMCITABINE; MELOXICAM; METHYLPHENIDATE; NAVELBINE; NEW DRUG; PACLITAXEL; PIOGLITAZONE; RIBAVIRIN; RILUZOLE; RIVASTIGMINE; ROFECOXIB; ROSIGLITAZONE; SIBUTRAMINE; TEMOZOLOMIDE; TETRAHYDROLIPSTATIN; TIROFIBAN; TOPOTECAN; ZANAMIVIR;

ARTICLE; COST EFFECTIVENESS ANALYSIS; DRUG APPROVAL; DRUG COST; DRUG EFFICACY; DRUG SAFETY; MEDICAL DECISION MAKING; PRIORITY JOURNAL;

EID: 0347755001     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10198-003-0190-5     Document Type: Article

References (26)

1. Burls A, Clark W, Stewart A, Preston C, Bryan S, Jefferson T et al (2001) Zanamivir for the treatment of influenza in adults. Available at: http://www.nice.org.uk/ (accessed 31 October 2001)
2. Chilcott J, Wight J, Jones M, Tappenden P (2001) The clinical effectiveness and cost-effectiveness of ploglitazone for type 2 diabetes mellitus Available at: http://www.nice.org.uk/ (accessed 31 October 2001)
3. Clegg A, Bryant J, Nicholson T, Gerrard K, McIntyre L, de Broe S, et al (2000) Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review. Health Technol Assess 5(1)
4. Department of Health (1999) Faster access to modern treatment: how NICE appraisal will work. Department of Health: Leeds
5. Dinnes J, Cave C, Huang S, Major K, Milne R (2001) The effectiveness and cost-effectiveness of temozolomide for the treatment of recurrent malignant glioma. Available at: http://www.nice.org.uk/ (accessed 31 October 2001)
6. Drummond M, O'Brien B, Stoddart G, Torrance G (1997) Methods for the economic evaluation of health care programmes. 2nd edn. Oxford University Press: New York
7. Forbes C, Shirran L, Bagnall AM, Duffy S, ter Riet G (2001) A rapid and systematic review of clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer. Available at: http://www.nice.org.uk/ (accessed 31 October 2001)
8. Health Economic Evaluations Database (2001) OHEIFPMA Database Ltd, November
9. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ (1996) Assessing the quality of reports of randomised clinical trials: is blinding necessary? Control Clin Trials 17:1-12
10. Lister-Sharp D, McDonagh MS, Khan KS, Kleijnen J (2000) A rapid and systematic review of the effectiveness and cost-effectiveness of the taxanes used in the treatment of advanced breast and ovarian cancer. Health Technol Assess 4(17)
11. Lord J, Paisley S (2000) The clinical effectiveness and cost effectiveness of methylphenidate for hyperactivity in childhood, version 2. National Institute for Clinical Excellence: London
12. Lord J, Paisley S, Taylor R (2000) The clinical effectiveness and cost effectiveness of rosiglitazone for type 2 diabetes mellitus. National Institute for Clinical Excellence: London
13. McDonagh M, Bachmann L, Golder S, Kleijnen J, ter Riet G (2000) A rapid and systematic review of the clinical effectiveness and cost-effectiveness of glycoprotein IIb/IIIa antagonists in the medical management of unstable angina. Health Technol Assess 4(30)
14. NHS (2001) Economic evaluation database. Available at: http://agatha.york.ac.uk/nhsdhp.htm (accessed 1 December 2001)
15. NICE Appraisal Team (2001) The clinical effectiveness and cost-effectiveness of celecoxib, rofecoxib, meloxicam and etodolac (Cox II inhibitors) for rheumatoid arthritis and osteoarthritis. Available at: http://www.nice.org.uk/ (accessed 31 October 2001)
16. O'Meara S, Riemsma R, Shirran L, Mather L, ter Riet G (2001) A systematic review of the clinical effectiveness and cost-effectiveness of orlistat in the management of obesity. Available at: http://www.nice.org.uk/cat.asp?c=1S712 (accessed 19 October 2001)
17. O'Meara S, Riemsma R, Shirran L, Mather L, ter Riet G (2001) A systematic review of the clinical effectiveness and cost-effectiveness of sibutramine in the management of obesity. Available at: http://www.nice.org.uk/ (accessed 31 October 2001)
18. Scott D, Clegg A, Sidhu M, Hewitson P, Waugh N (2001) Clinical and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in lung cancer. Available at: http://www.nice.org.uk/ (accessed 31 October 2001)
19. Sculpher M, Fenwick E, Claxton K (2000) Assessing quality in decision analytic cost-effectiveness models. Pharmacoeconomics 17:461-477
20. Sheldon TA (1996) Problems of using modelling in the economic evaluation of health care. Health Econ, 5:1-11
21. Shepherd J, Waugh N, Hewitson P (2000) Combination therapy (interferon alfa and ribavirin) in the treatment of chronic hepatitis c: a rapid and systematic review. Health Technol Assessment 4(33)
22. Smith, R (1999) What is publication? BMJ 318:142
23. Stewart A, Sandercock J, Bryan S, Hyde C, Fry-Smith A, Burls A (2001) The clinical effectiveness and cost-effectiveness of riluzole for motor neurone disease. Available at: http://www.nice.org.uk/ (accessed 31 October 2001)
24. Sullivan SD, Lyles A, Luce B, Gricar J (2001) AMCP guidance for submissions of clinical and economic evaluation data to support formulary listing in United States health plans and pharmacy benefit management organizations. J Manage Care Pharm 7:272-282
25. Wake B, Bryan S, Barton P, Fry-Smith A, Davenport C, Song F et al (2001) Fludarabine as second line therapy for B-cell chronic lymphocytic leukamia. Available at: http://www.nice.org.uk/ (accessed 31 October 2001)
26. Ward S, Bansback N, Morris E, Calvert N (2001) A review of clinical and cost-effectiveness of gemcitabine for the treatment of pancreatic cancer. Available at: http://www.nice.org.uk/ (accessed 31 October 2001)